Analysis of Borrelia burgdorferi Surface Proteins as Determinants in Establishing Host Cell Interactions by Virginia L. Schmit et al.
ORIGINAL RESEARCH ARTICLE
published: 01 July 2011
doi: 10.3389/fmicb.2011.00141
Analysis of Borrelia burgdorferi surface proteins as
determinants in establishing host cell interactions
Virginia L. Schmit†,Toni G. Patton and Robert D. Gilmore Jr.*
Bacterial Diseases Branch, Division of Vector Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and
Prevention, Fort Collins, CO, USA
Edited by:
Robert Heinzen, NIH/NIAID-RML,
USA
Reviewed by:
Michael F. Minnick, The University of
Montana, USA
Edward Shaw, Oklahoma State
University, USA
*Correspondence:
Robert D. Gilmore Jr., Division of
Vector Borne Diseases, Centers for
Disease Control and Prevention, 3150
Rampart Rd., Fort Collins, CO 80521,
USA.
e-mail: rbg9@cdc.gov
†Present address:
Virginia L. Schmit, Chemistry
Department, University ofWyoming,
Laramie,WY, USA.
Borrelia burgdorferi infection causes Lyme borreliosis in humans, a condition which can
involve a systemic spread of the organism to colonize various tissues and organs. If the
infection is left untreated by antimicrobials, it can lead to manifestations including, arthritis,
carditis, and/or neurological problems. Identiﬁcation and characterization of B. burgdor-
feri outer membrane proteins that facilitate cellular attachment and invasion to establish
infection continue to be investigated. In this study, we sought to further deﬁne putative
cell binding properties of surface-exposed B. burgdorferi proteins by observing whether
cellular adherence could be blocked by antibodies. B. burgdorferi mixed separately with
monoclonal antibodies (mAbs) against outer surface protein (Osp) A, OspC, decorin-binding
protein (Dbp) A, BBA64, and RevA antigens were incubated with human umbilical vein
endothelial cells (HUVEC) and human neuroglial cells (H4). B. burgdorferi treated with
anti-OspA, -DbpA, and -BBA64 mAbs showed a signiﬁcant decrease in cellular associa-
tion compared to controls, whereas B. burgdorferi treated with anti-OspC and anti-RevA
showed no reduction in cellular attachment. Additionally, temporal transcriptional analyses
revealed upregulated expression of bba64, ospA, and dbpA during coincubation with cells.
Together, the data provide evidence that OspA, DbpA, and BBA64 function in host cell
adherence and infection mechanisms.
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INTRODUCTION
Lyme borreliosis, or Lyme disease in humans, is the result of
an infection with the spirochete Borrelia burgdorferi. This tick-
borne illness typically exhibits a rash (termed erythema migrans)
at the tick-bite site, and can progress to more severe conditions
if left untreated. After introduction into the skin, the organ-
ism systemically disseminates and colonizes other tissues and
organs ultimately resulting in arthritis, carditis, and/or neurolog-
ical manifestations (Steere, 2001). The processes underlying the
spirochete’s ability to spread and localize to host tissues leading to
the pathology of Lyme disease are not fully deﬁned.
Borrelia burgdorferi adapts to the varying environments
encountered during its enzootic cycle through ticks and mam-
mals by undergoing differential gene expression. For example,
the organisms are relatively dormant in an unfed tick; however
during tick feeding, B. burgdorferi becomes metabolically active
by turning on genes encoding proteins essential for survival,
replication, and transmission. Accordingly, once inside the mam-
malian host, B. burgdorferi regulates gene expression to facilitate
infection. The number of genes expressed and gene products syn-
thesized during mammalian infection is evidenced by the robust
antibody response against a large number of borrelial antigens
(Dressler et al., 1993). Some in vivo differentially expressed genes
encode surface lipoproteins that have been identiﬁed as adhesins
that mediate binding to molecules present in the extracellular
matrix or on host cells of tissues (Coburn et al., 2005). Borrelial
surface-exposed proteins decorin-binding protein (Dbp) A and
B, BBK32, ErpX, RevA, Bgp, P66, BBB07, BmpA, CRASP-1, and
outer surface protein (Osp) A, bind ﬁbronectin, decorin, laminin,
integrins, and other glycosaminoglycans and proteoglycans (Guo
et al., 1998; Probert and Johnson,1998; Pal et al., 2000; Parveen and
Leong, 2000; Coburn andCugini, 2003; Zambrano et al., 2004; Fis-
cher et al., 2006; Rupprecht et al., 2006; Behera et al., 2008; Brissette
et al., 2009a,b; Verma et al., 2009; Hallstrom et al., 2010).
Numerous studies have demonstrated borrelial adherence to
and/or invasion of several cell types in vitro (Garcia-Monco et al.,
1989; Szczepanski et al., 1990; Comstock and Thomas, 1991; Ma
et al., 1991; Klempner et al., 1993; Kurtti et al., 1993; Girschick
et al., 1996; Peters and Benach, 1997; Leong et al., 1998; Cinco
et al., 2001; Fischer et al., 2003; Livengood and Gilmore, 2006;Wu
et al., 2011). However, knowledge of speciﬁc processes mediated
by known B. burgdorferi surface proteins for cell and tissue colo-
nization, as well as the identiﬁcation of novel proteins involved
in host cell infections is lacking. In a previous study, we uti-
lized global transcriptome analysis to examine B. burgdorferi gene
expression during human host cell interactions as an initial step
to identify proteins involved in cellular colonization, including
adherence and invasion (Livengood et al., 2008).We hypothesized
that genes upregulated in response to host cell signalsmay function
in establishing B. burgdorferi infection. In this study, we examined
whether B. burgdorferi binding to human cells could be blocked by
antibodies directed against more well-characterized surface
lipoproteins identiﬁed by the microarray (i.e., DbpA, BBA64,
OspA, OspC, and RevA). Additionally, we measured transcription
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of these borrelial genes to observe the level of regulation in
response to cellular interaction.
MATERIALS AND METHODS
MONOCLONAL ANTIBODIES, INDIRECT IMMUNOFLUORESCENCE (IFA)
AND IMMUNOBLOTTING OF CULTURED B. BURGDORFERI
Monoclonal antibodies (mAbs) against BBA64, DbpA, and the
anti-Bartonella protein were obtained from Barbara J. B. John-
son (CDC, Fort Collins, CO, USA). Anti-BBA64 and -DbpA were
generated by recombinant protein immunization, and the anti-
Bartonella mAb was generated by whole cell lysate immunization
utilizing standard procedures for generating hybridomas in mice
(Mbow et al., 2002). The anti-Bartonella mAb was reactive to a
70-kDa band on immunoblot against a rodent-derived Bartonella
isolate.Anti-Rev and -OspC (B5)mAbswere generated by tick-bite
inoculation of mice and have been described previously (Gilmore
andMbow,1998;Mbowet al., 1999,2002).Anti-OspAmAbH5332
was provided by Alan Barbour, UC-Irvine.
Immunoﬂuorescent staining of culturedB. burgdorferi was per-
formed as follows. B. burgdorferi low passage, infectious, clonal
strain B31-A3 (Elias et al., 2002) was grown in complete Barbour-
Stoenner-Kelly (BSK-II) medium at 34˚C in capped tubes. Cul-
tures were grown to mid-to-late logarithmic stage (approx.
5× 107–1× 108 organisms/ml), and 2× 106 bacteria were spun
onto Cytospin microscope slides using a Shandon Cytospin 4
(Thermo Electron Corporation, Waltham, MA, USA). After cen-
trifugation, slides were air dried, incubated in blocking solution
(2% bovine serum albumin in phosphate buffered saline pH 7.5
[BSA–PBS]) for 1 h at room temperature (rt), and then incubated
with the speciﬁc mAb (1:75 dilution) for 1 h Slides were washed
(3× with PBS) and stained with goat anti-mouse IgG Alexaﬂuor
594 (Molecular Probes, Eugene, OR, USA) at a 1:75 dilution for
45m. Slides were washed (3× with PBS) and probed with FITC-
conjugated goat anti-Borrelia burgdorferi IgG (KPL,Gaithersburg,
MD, USA) at a 1:75 dilution for 45m. Slides were washed (3×
with PBS), air dried, and overlaid with Prolong AntiFade (Mol-
ecular Probes) and coverslips prior to imaging by epiﬂuorescent
microscopy.
Immunoblotting was performed as follows. B. burgdorferi were
collected from culture and washed in PBS prior to gel fractiona-
tion. Cell lysates were denatured by boiling for 10min in Laemmli
buffer containing 5% 2-mercaptoethanol and subjected to sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
on a 10–20% gradient gel followed by transfer to nitrocellulose
ﬁlters according to standard procedures. Immunoblots were incu-
bated with the appropriate mAb (1:5000 dilution) for 1 h, washed
with PBS (3× at 5min), followed by incubation with alkaline
phosphatase conjugated goat anti-mouse IgG (1:2000) for 1 h.
After PBS wash, the blot was developed colorimetrically with NBT
(nitro-blue tetrazolium chloride) and BCIP (5-bromo-4-chloro-
3′-indolyphosphate p-toluidine salt) substrate.
MAMMALIAN CELL CULTURE
Human umbilical vein endothelial cells (HUVEC) and human
neuroglial cells (H4) were obtained from American Type Cul-
ture Collection (Manassas, VA, USA; ATCC catalog numbers
CRL-1730 and HTB-178 respectively). HUVECs were grown
in F12-K medium supplemented with 0.1mg/ml heparin,
0.03mg/ml endothelial cell growth supplement, and 10% fetal
bovine serum. The H4 cells were grown in Dulbecco’s modiﬁed
eagle’s medium (DMEM) supplemented with 10% fetal bovine
serum. Both cell lines were grown at 37˚C in the presence of
5% CO2 in a humidiﬁed environment. Cells were harvested from
conﬂuent monolayers with 0.05% trypsin – 10mM EDTA and
enumerated on a hemocytometer cell counter.
BORRELIA BURGDORFERI -CELL COINCUBATION ASSOCIATION ASSAYS
HUVEC and H4 cells were seeded at a concentration of 3× 105
cells/chamber on Lab-Tek II CC chamber slide system (Nalge
Nunc International, Rochester, NY, USA), and allowed to adhere
overnight. Prior to addition to cells, individual B. burgdorferi
aliquots, at a multiplicity of infection (MOI) of 40 (1.2× 107),
were preincubated (35˚C shaking at 150 rpm for 30m) with each
anti-B. burgdorferi mAb or control in 0.5ml volume. Following
incubation with the appropriate antibody, B. burgdorferi were
added to each cell well. The antibody concentration used was
pre-determined empirically by a series of 10-fold dilutions for
each mAb to ascertain the highest dilution of antibody that pro-
duced signiﬁcant reduction in cell binding. Anti-BBA64, -DbpA,
and -OspA were used at 1:500, 1:5000, and 1:5000 respectively.
The coincubation experiments were performed in duplicate using
these dilutions. Additionally, three control B. burgdorferi pre-cell
incubation treatments were tested: (i) mAb suspension buffer only
(50% glycerol/1× PBS); (ii) a non-Borrelia-speciﬁc mAb (anti-
Bartonella antibody); and (iii) no antibody (with 1× PBS added
to volume).
Followingovernight coincubationof treatedB. burgdorferi with
human cells, slide chambers were gently washed 3× with PBS to
remove non-adherent bacteria. Cells with associated bacteria were
ﬁxed on the slide chamber with 4% paraformaldehyde for 45m at
rt. Fixed cells were washed followed by blocking with 2%BSA-PBS
for 1 h. Mammalian cells were stained with Alexa 594 Phalloidin
(1:200 dilution; Molecular Probes) for 10m at rt. Samples were
washed, then cells were permeabilized with 2% BSA-PBS sup-
plemented with 0.5% Triton X-100 for 45m at rt. B. burgdorferi
were stained with FITC-conjugated goat anti-B. burgdorferi (1:75
dilution) for 1 h.
Samples were visualized on a LSM5Pascal confocalmicroscope
(Carl Zeiss, USA). Micrograph images were acquired at 100× and
250×magniﬁcation. B. burgdorferi associated with cells were enu-
merated microscopically. Counts were made for (1) total human
cells/ﬁeld, and (2) Borrelia associated with cells/ﬁeld,with 30 indi-
vidual ﬁelds observed and counted from each slide. From the sum
of the 30 ﬁelds, the average number of B. burgdorferi associated
per cell was determined. The percent reduction in cell attachment
was calculated by the difference between the antibody-treated B.
burgdorferi and the control treatment. Assays were performed
in duplicate. Comparisons of the data were performed using a
two-sample t -test. Differences were considered signiﬁcant if
p-value was ≤0.05.
RNA ISOLATION FROM B. BURGDORFERI -ASSOCIATED CELLS
HUVEC or H4 cells were grown to conﬂuence in a 150 cm2 cell
culture ﬂask, trypsinized, and enumerated, from which 2× 105
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cells were seeded in six well cell culture plates and were allowed
to adhere for 17 h at 37˚C with 5% CO2. Log-phase B. burgdor-
feri cultures were centrifuged for 10m at 9300× g, with aliquots
resuspended in F-12K or DMEM cell culture media and added to
the HUVECs, H4 cells, or media alone at a MOI of 40 (7.8× 107
bacteria). Plates were incubated at 34˚C with 5% CO2. Cell wells
were inoculated concurrently in triplicate and harvested for RNA
isolation at 2-, 4-, 8-, 24-, and 48-h post-inoculation. At the appro-
priate time, cell culture media was removed, and the plate was
washed 3× with 5ml PBS to remove non-adherent bacteria. Cells
with adherent bacteria were removed with cell scrapers in 300μl
RNAlater (Ambion, Austin, TX, USA). Media from the cell-free
Borrelia wells were centrifuged at 9300× g for 5min, washed 2×
with 5ml PBS, and resuspended in 300μl RNAlater. RNAlater
samples were stored overnight at 4˚C and then at −20˚C until
the RNA was puriﬁed. Prior to RNA extraction, the samples were
centrifuged at 16,000× g for 10 m, the RNAlater was decanted,
followed by total RNA extraction using RNAqueous RNA isola-
tion kit (Ambion). Contaminating DNA was removed using the
TURBO DNA-free kit (Ambion). RNA samples were tested for
contaminating DNA by PCR prior to cDNA synthesis. Total RNA
was quantiﬁed by spectrophotometry and RNA integrity was ana-
lyzed using an Agilent 2100 Bioanalyzer with Agilent RNA Pico
Reagents (Agilent Technologies, Boulder CO).
QUANTITATIVE REVERSE TRANSCRIPTASE PCR (QRT-PCR)
Puriﬁed total RNA (100 ng) isolated from the B. burgdorferi-
associated cells was used to synthesize cDNA using SuperScript
II Reverse Transcriptase (Invitrogen, Carlsbad, CA, USA) and
random decamers. Real-time PCR was performed with TaqMan
Universal PCRMasterMix (Applied Biosystems) using ﬂaB,bba64,
dbpA, and ospA TaqMan probe and primers described previously
(Livengood et al., 2008). Real-time PCR reactions, performed in
triplicate per sample, contained 1μl cDNA, 1μM5′ primer, 1μM
3′ primer, 0.1μM probe, and 1× TaqMan Universal PCR Master
mixture in a total volume of 12.5μl. Ampliﬁcation parameters
consisted of 1 cycle at 95˚C for 10m and 50 cycles of 95˚C for 30 s
and 60˚C for 1m, with data collection after each cycle in a Bio-
Rad iCycler (BioRad, Hercules, CA, USA). The iCycler software
determined crossing threshold (CT) values. B. burgdorferi gene
expression during coincubation with cells was determined rela-
tive to borrelial gene expression in cell-free tissue culture media
using the 2−CT method (Livak and Schmittgen, 2001), and was
normalized against the constitutively expressed ﬂaB gene.
RESULTS
PROTEIN SYNTHESIS BY IN VITRO CULTIVATED B. BURGDORFERI
Cultured B. burgdorferi was assessed for the production of OspA,
DbpA, BBA64, OspC, and RevA prior to antibody treatment and
coincubation with tissue culture cells. Analysis of cultured organ-
isms by IFA demonstrated in vitro production of the individual
proteins (Figure 1A). Immunoblot analysis of cultured borrelial
lysates also showed protein production (Figure 1B).
COINCUBATION OF ANTIBODY-TREATED B. BURGDORFERI WITH
HUVEC AND H4 CELLS
Borrelia burgdorferi were preincubated with the mAbs for 30m
prior to placement on HUVEC and H4 cells. Following the
FIGURE 1 | Production of proteins from cultured B. burgdorferi . (A)
Representative images of immunoﬂuorescent dual staining of organisms
with the speciﬁc mAb (noted above panels) and anti-B. burgdorferi
antibody. Punctate staining of surface proteins are labeled red; whole cell
B. burgdorferi are stained green. (B) Immunoblots of B. burgdorferi lysates
using the speciﬁed mAbs.
antibody incubation, a sample of the spirochetes were visualized
under darkﬁeld microscopy to determine viability. B. burgdorferi
treated with each mAb were motile indicating that the antibody
treatment was not borreliacidal.
An experiment was performed to ﬁnd the least concentrated
mAb solution that produced signiﬁcant differences (p< 0.05) in
cell binding from the no antibody control treatment. We consid-
ered that higher dilutions of mAb would provide less chance for
steric hindrance that could lead to non-speciﬁc blocking. The opti-
mal dilutions were determined to be 5× 10−3 for the anti-OspA
and -DbpA mAbs, and 5× 10−2 for the anti-BBA64 antibody.
Anti-RevA and anti-OspC mAbs, at all dilutions tested, demon-
strated no signiﬁcant inhibition of binding to HUVEC or H4 cells
when compared to the no antibody control (data not shown).
Additionally, there were no signiﬁcant differences between
numbers of B. burgdorferi attached to host cells follow-
ing each of the control treatments, i.e., Borrelia prein-
cubated with antibody buffer only, Borrelia preincubated
with non-speciﬁc antibody, and Borrelia preincubated with
only PBS (data not shown). Therefore, the control data
reported (as “without” or “no antibody”) in the text reﬂect
counts obtained with the non-speciﬁc anti-Bartonella antibody
pretreatment control.
Table 1 shows associatedB. burgdorferi/100 cells with andwith-
out speciﬁc mAb treatment and the calculated reduction in B.
burgdorferi cellular attachment. B. burgdorferi treated with anti-
OspA, -DbpA, and -BBA64 antibodies demonstrated signiﬁcant
decreases in HUVEC and H4 cell binding when compared to Bor-
relia treated with the control. (As mentioned above, treatment
with anti-OspC and anti-RevA had no effect on binding). The
reduction in attachment between antibody treatments in separate
experiments ranged from 30.6 to 55.2% for both HUVEC and H4
cells. The average B. burgdorferi/100 cells counted from 30 ﬁelds
in each experiment were signiﬁcantly different between antibody-
treated Borrelia and controls (p < 0.001). An additive effect in
attachment reduction when all three antibodies were combined
was not observed. Figure 2 shows images of representative ﬁelds
of B. burgdorferi binding to HUVECs and H4 cells respectively,
with and without antibody treatment, allowing a visual inspection
of the diminished attachment.
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Table 1 | Reduction in B. burgdorferi binding to HUVEC and H4 cells
following treatment with anti-B. burgdorferi surface protein
antibodies.
Average B. burgdorferi/100 cellsa (SD)
Cell type/
experiment #
Antibody treatment Attachment
reductionb (%)
Anti-OspA Control
HUVEC/Exp. 1 17.6 (12.6) 37.3 (15.1) 52.8
HUVEC/Exp. 2 33.8 (13.5) 53.7 (19.8) 37.1
H4/Exp. 1 6.7 (3.2) 12.5 (4.8) 46.4
H4/Exp. 2 11.1 (4.0) 16.0 (5.9) 30.6
Anti-DbpA Control
HUVEC/Exp. 1 12.7 (6.1) 26.3 (8.8) 51.8
HUVEC/Exp. 2 12.7 (4.2) 26.6 (8.8) 52.3
H4/Exp. 1 5.9 (1.7) 9.9 (3.3) 40.4
H4/Exp. 2 27.3 (7.9) 47.6 (10.6) 42.6
Anti-BBA64 Control
HUVEC/Exp. 1 12.5 (4.3) 27.9 (7.5) 55.2
HUVEC/Exp. 2 19.9 (6.6) 29.2 (7.4) 31.8
H4/Exp. 1 32.9 (7.9) 52.1 (9.4) 36.9
H4/Exp. 2 4.7 (1.4) 9.5 (3.4) 50.5
Anti-BBA64,
-OspA, -DbpA
Control
HUVEC/Exp. 1 39.1 (9.6) 61.5 (9.8) 36.4
HUVEC/Exp. 2 20.4 (6.8) 53.7 (19.8) 62.0
H4/Exp. 1 37.3 (7.9) 46.7 (7.8) 20.1
H4/Exp. 2 12.6 (4.0) 16.0 (5.8) 21.2c
a30 ﬁelds counted.
bP< 0.0001.
cP< 0.01.
FIGURE 2 | Confocal microscopy of fluorescent-stained B. burgdorferi
bound to HUVEC and H4 cells. Panels on the left show Borrelia
attachment with no antibody treatment (i.e., the anti-Bartonella control);
panels on the right show Borrelia attachment following incubation with
anti-surface protein mAb. (A) anti-OspA; (B) anti-DbpA; (C) anti-BBA64.
OspA, DbpA, AND BBA64 GENE EXPRESSION DURING COINCUBATION
WITH HOST CELLS
Antibodies directed against OspA, DbpA, and BBA64 attenuated
the ability of B. burgdorferi to bind to host cells in vitro suggesting
that these surface proteinsmay play a role in establishing infection.
Therefore, we hypothesized that the genes encoding these pro-
teinsmay be upregulated during cellular interaction.We employed
qRT-PCR to monitor B. burgdorferi gene expression temporally
throughout the incubation period with the tissue culture cells. We
found that in both H4 andHUVEC interactions, dbpA, bba64, and
ospA expressionwere generally elevated compared toB. burgdorferi
incubation in cell-free environment.
dbpA expression was the highest of the three genes in both
HUVEC and H4 incubations. At 2-h post-inoculation, gene
expression was approximately 150-fold higher in HUVEC than
in cell-free media (Figure 3A). dbpA expression continued to be
elevated at approximately 20-fold at 4-, 8-, 24-, and 48-h post-
inoculation in HUVECs compared to the control. dbpA also was
upregulated in H4 cells throughout the incubation period, with a
peak around 60-fold at 48 h (Figure 3A).
bba64 expression measured at 2- to 8-h post-inoculation with
HUVECs was between approximately ﬁve- to sevenfold higher
than in cell-free media (Figure 3B). At 24-h post-inoculation,
expression was detected but was not signiﬁcantly increased com-
pared to B. burgdorferi in cell-free media. However, by 48 h,
expression had decreased below the cell-free level. In H4 cells,
bba64 expression was detected early, but not at signiﬁcantly
higher levels than in cell-free organisms. However, expression
increased several-fold by 8-h post-inoculation, and remained ele-
vated compared with the cell-free control at 48-h post-inoculation
(Figure 3B).
ospA expression was detectable and slightly elevated in
HUVECs in early time points post-inoculation when compared
to expression in cell-free media. At 2 h into the incubation period,
an approximate threefold increase in expression was observed.
At 4-h post-inoculation, the expression level had decreased from
2 h, although a signiﬁcant increase from cell-free expression was
detected at 8 h. Later in the incubation, at 24 and 48 h,ospA expres-
sion had decreased to levels below that in cell-freemedia. A similar
pattern was observed in H4 cells where there was no signiﬁcant
difference between expression in cell-free conditions, except at 8 h
incubation whereby there was an approximate twofold increase
(Figure 3C).
DISCUSSION
Colonization of host tissues by B. burgdorferi is a key factor in the
pathogenesis of Lyme borreliosis. However, the mechanisms by
which B. burgdorferi interacts with host cells to facilitate attach-
ment, invasion, and colonization are poorly understood. To gain
insight into B. burgdorferi genes that encode proteins required
for human cell interactions, we hypothesized in an earlier study
that genes upregulated during host cell infection may have roles
in adherence, invasion, and colonization. In that study, we per-
formed a global analysis of B. burgdorferi gene expression by
microarray following coincubation of Borrelia with human neu-
roglial cells and found several genes to be upregulated during the
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FIGURE 3 | (A) dbpA gene expression in HUVEC (left graph) and H4 cells (right graph); (B) bba64 gene expression in HUVEC (left graph) and H4 cells (right
graph); (C) ospA gene expression in HUVEC (left graph) and H4 (right graph).
cellular interaction (Livengood et al., 2008). Among the upregu-
lated genes identiﬁed by the microarray study were ospA, dbpA,
and bba64. Other studies have shown ospC and revA to encode
products that functioned in establishing mammalian infection
and in ﬁbronectin-binding respectively (Grimm et al., 2004; Bris-
sette et al., 2009a). Therefore, we initiated the current study to
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determine if mAbs directed against these surface proteins could
prevent or reduce the establishment of host cell attachment, and
if so, assay expression of the genes during cellular association.
We ﬁrst determined that cultured B. burgdorferi produced the
target proteins prior to antibody treatment and cell incubation.
Second, after mixing B. burgdorferi and the mAbs we ensured
that the antibody was not bactericidal and that the spirochetes
were still motile. With these requirements satisﬁed, B. burgdorferi
incubated with and without speciﬁc antibody were coincubated
in tissue culture with the human host cells. Three of the ﬁve
anti-surface protein antibodies, anti-OspA, anti-DbpA, and anti-
BBA64, signiﬁcantly reduced B. burgdorferi binding to H4 and
HUVECs (Table 1; Figure 2).
In an earlier study by Comstock et al. (1993), a mAb directed
against OspA (9B3D) was shown to inhibit binding to HUVECs,
therefore our anti-OspA treatment served as a positive control
and allowed us to corroborate the ﬁnding with a mAb directed
against OspA. The antibodies directed against RevA or OspC had
no inhibitory effect on B. burgdorferi binding, suggesting these
proteins do not play a role in attachment to HUVEC or H4 cells.
RevA is expressed during mammalian infection and has recently
been shown to be a ﬁbronectin-binding protein, but its function
is unknown (Gilmore and Mbow, 1998; Brissette et al., 2009a).
OspC has been studied more extensively and is required by B.
burgdorferi to establish infection in the mammalian host (Grimm
et al., 2004). Because mAbs speciﬁc for a single epitope on the
protein were used, we cannot discount that polyclonal antibod-
ies directed against other determinants of OspC or RevA could
provide a blocking effect. However, the anti-OspC mAb used here
has been shown to protect against B. burgdorferi challenge when
passively administered (Mbow et al., 1999). Therefore the failure
of this mAb to inhibit cell adherence suggests that OspC does not
function in cellular interactions (at least for these cell types) to pro-
mote infection. The lack of effect on cell binding with these two
antibodies also provided evidence that the reduction in attachment
measured with the anti-OspA, -DbpA, and -BBA64 antibodies was
not due to non-speciﬁc inhibition.
The results of the antibody blocking experiments suggested that
OspA, BBA64, and DbpA can mediate B. burgdorferi attachment
to human cells, and that their production may be necessary for
cell and tissue colonization. Therefore, we measured B. burgdor-
feri gene expression during coincubation with the host cells, and
found that dbpA, ospA, and bba64 expression were elevated during
interactions with both cell types.
dbpA was highly upregulated, throughout the 48-h experiment,
when B. burgdorferi were incubated with HUVECs and H4 cells.
DbpA is an adhesin that binds decorin. a protein linked to the gly-
cosaminoglycan (GAG) dermatan sulfate/chondroitin sulfate and
is most commonly associated with collagen, but is present inmany
tissues (Guo et al., 1995, 1998). Proteoglycans are receptors for B.
burgdorferi adherence to several cell types, with speciﬁc classes of
GAGs playing key roles in the spirochetal binding activity (Leong
et al., 1998). Fischer et al. (2003) showed that transformation of
a non-adherent strain of B. burgdorferi lacking the dbpBA operon
with dbpA could restore binding to human epithelial cells. Our
observation of dbpA upregulation in response to interactions with
host cells, combinedwith the reduction in cell binding by antibody
reinforces ﬁndings from earlier studies linking DbpA production
with cell attachment, tissue colonization and host immune resis-
tance (Liang et al., 2004; Blevins et al., 2008; Shi et al., 2008b;
Weening et al., 2008).
bba64 was also expressed during B. burgdorferi interactions
with HUVEC and H4 cells. Recently we demonstrated that bba64
was necessary for mammalian infection via tick transmission, and
that bba64 is upregulated in ticks during bloodmeal ingestion
(Gilmore et al., 2010; Patton et al., 2011). In addition, we have
shown bba64 expression in mouse tissues throughout persistent
infection, suggesting a role in host pathogenesis, possibly by func-
tioning in the establishment and maintenance of the organism in
various tissue (Gilmore et al., 2007, 2008). The upregulation of
bba64 expression when coincubated with human cells implicates
BBA64 as a multifunctional protein involved in tick transmission
and mammalian host cell interactions.
Previous studies have implicated OspA in cell adherence even
though ospA is downregulated in the tick during feeding, and is
not expressed in the host in the acute phases of infection. Rup-
precht et al. (2006) demonstrated that OspA from B. garinii, a B.
burgdorferi sensu lato strain most frequently associated with Lyme
neuroborreliosis in Europe, mediates adherence to neuronal cells
in vitro. Also, Comstock et al. (1993) showed that a mAb against
OspA could inhibit borrelial association with HUVECs. In our
study, ospA was expressed, and signiﬁcantly upregulated early in
response to HUVEC interaction, and at 8-h post-inoculation in
H4 cells. The early expression of ospA may reﬂect an unknown
function relating to host cell attachment, with downregulation of
expression later after the spirochetes have established cellular col-
onization. However, because ospA is minimally or not expressed
at the time of mammalian entry, the role of OspA in mediating
cellular interactions remains to be determined.
Generation of B. burgdorferi mutant isolates, whereby ospA,
dbpA, and bba64 have been inactivated, have led to studies to
deﬁne the role of these genes in host infectivity and pathogen-
esis. Attenuated tissue colonization and host persistence has been
shown in mice injected with mutant B. burgdorferi lacking dbpA,
and decorin-deﬁcient mouse strains demonstrated resistance to
experimental infection by both needle and tick bite (Brown et al.,
2001; Blevins et al., 2008; Shi et al., 2008a;Weening et al., 2008). In
contrast, ospA- and bba64-knockout mutants (when introduced
by needle inoculation) were not impaired in their ability to infect
or persist in mice (Yang et al., 2004; Battisti et al., 2008;Maruskova
et al., 2008; Gilmore et al., 2010). Despite being dispensible for
mouse infection via needle inoculation of cultured organisms,
bba64 is highly expressed by wild-type organisms in several tis-
sues during persistent infection in vivo (Gilmore et al., 2008). It
is becoming clear that B. burgdorferi binding and colonization
of host cell tissues is a complex process mediated by numerous
adherence components produced by B. burgdorferi, which may
contribute to functional redundancy during infection. Perhaps
such redundancy provides a survival advantage to host-adapted B.
burgdorferi to evade host immunity, or a combination of proteins
are regulated towork synergistically to optimally colonize the host.
In conclusion, we have demonstrated that antibodies directed
againstOspA,DbpA, andBBA64 can signiﬁcantly reduce the bind-
ing ability of B. burgdorferi to human endothelial and neuroglial
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cells. Additionally, we have shown that ospA, bba64, and dbpA
are expressed and upregulated during times of B. burgdorferi-
host cell interactions in vitro. Collectively, these ﬁndings infer
that these outer surface proteins contribute to borrelial attach-
ment and host cell colonization. Future studies will address the
mechanisms employed by these gene products in cellular infection
by utilizing mutant strains with inactivated dbpA, bba64, ospA to
interface with human cells in tissue culture. Additionally, we seek
to identify novel B. burgdorferi genes that are upregulated during
interactions with human cells as a means to understand and char-
acterize the response of this pathogen to host components during
infection.
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